(Press-News.org) Offering a potential early intervention for Alzheimer's disease (AD), researchers at University of California, San Diego School of Medicine and Cenna Biosciences, Inc. have identified compounds that block the production of beta amyloid peptides in mice. The study is reported April 29 in PLOS ONE.
If the results ultimately translate to human treatment, the most promising compound - a peptide dubbed P8 - could be administered to individuals at high risk of developing the disease, long before the tell-tale signs of dementia occur and perhaps with few side effects, due to the compound's highly specific mode of action.
"Our approach is completely different from any current approaches that target beta amyloid," said lead author Nazneen Dewji, PhD, associate adjunct professor in the Department of Medicine. "We are blocking the actual production of beta amyloid in a new way. It's very promising because it means that, in principle, we can stop the disease in its tracks."
The build-up of beta amyloid plaques is widely believed to cause irreversible brain damage, resulting in a host of cognitive and motor impairments broadly associated with AD, which accounts for about 60 to 80 percent of all cases of dementia in the United States.
Because of the currently perceived role of beta amyloid in disease progression, several investigational drugs have targeted the enzymes that cleave beta amyloid from its larger precursor protein, the aptly named amyloid precursor protein (APP).
"These drugs, however, have largely failed in clinical trials," said Dewji, "mostly because they are responsible for cleaving other proteins besides APP. Inhibiting or modifying their activities creates many undesirable effects in the cell."
The P8 compound does not act on enzymes, but rather binds to APP and in so doing, prevents the larger protein from being processed into smaller amyloid peptides. The compounds are derived from a fragment of a membrane protein known as presenilin 1 that is known to interact with APP to produce beta amyloid. The highly specific binding between the APP and P8 was measured using both biophysical methods and optical imaging techniques.
"Our approach is different, specific and interferes with only the reaction that produces beta amyloid, as opposed to drugs that target the enzymes responsible for its cleavage from APP, which can affect multiple reactions in cells," said Dewji, who is also president and CEO of the La Jolla-based biopharmaceutical company Cenna, where the drug candidates are being developed.
In addition to cell culture experiments, researchers also conducted experiments with mice, engineered to produce large amounts of the human beta amyloid early in life.
Their experiments showed that a two-week course of treatment with either P8 or another compound called P4 resulted in, on average, a greater than 50 percent reduction in plaque accumulation, as compared with mice who received no treatment.
"We now have a new approach for the treatment of Alzheimer's disease that can arrest the production of beta amyloid very early and specifically," she said. "It's a real chance at a successful treatment for Alzheimer's disease."
Other co-authors include Eliezer Masliah, Edward Rockenstein, Martha Harber, and Taylor Horwood, UC San Diego; and Mihyun Kim, UC San Diego and Cenna Biosciences.
INFORMATION:
Funding for the study came, in part, from National Institutes of Health (grants 5RO1NS055161, 5RO1AG17888 and 1R43AG043278) and Alzheimer's Drug Discovery Foundation.
Disclosure: Dewji and co-author S. Jonathan Singer, PhD, professor emeritus in the Division of Biological Sciences, founded Cenna in 2006. The technology that forms the basis of Cenna's approach and lead compounds is covered by U.S. and foreign patent applications filed by UC San Diego and exclusively licensed to Cenna.
Understanding extinct species diets may require a greater understanding of the relationship between skull biomechanics and the animals' ancestry than previously thought, according to a new study published April 29, 2015 in the open-access journal PLOS ONE by Zhijie Jack Tseng and John Flynn from the American Museum of Natural History.
The diet of long-extinct animals may be inferred by using modern animals with similar skull shapes and tooth patterns as models, but scientists aren't sure if diet is the main factor influencing skull shape and biomechanics. To understand ...
April 24, 2015. Almost since the time of Melville's epic hunt, scientists have been fascinated by the remarkable attributes of the sperm whale and its kin, the smaller pigmy and dwarf whales. Capable of diving to great depths and gifted with an acute sense of echolocation, these animals have remained inseparable from maritime lore.
An international team of scientists, led by the Natural History Museum of Los Angeles County's Curator of Marine Mammals Dr. Jorge Velez-Juarbe, has discovered a new species of an extinct pigmy sperm whale from Panama that clarifies key aspects ...
(Philadelphia, PA) - For more than 100 years, exposing students to basic and clinical research has been an essential component of a medical school education in the United States. However, today, new models of medical education in which research plays a minimal role are likely to create a two-tiered system of education, decrease the physician-scientist pipeline and diminish the application of scientific advances to patient care.
Those are the concerns outlined in "American Medical Education at a Crossroads" - a position paper published April 29 by Science Translational ...
ANN ARBOR, Mich. -- Kaiba was just a newborn when he turned blue because his little lungs weren't getting the oxygen they needed. Garrett spent the first year of his life in hospital beds tethered to a ventilator, being fed through his veins because his body was too sick to absorb food. Baby Ian's heart stopped before he was even six months old.
Three babies all had the same life-threatening condition: a terminal form of tracheobronchomalacia, which causes the windpipe to periodically collapse and prevents normal breathing. There was no cure and life-expectancies were ...
Having to pay for dental health care can put a considerable strain on household finances in many countries, according to an international study led by King's College London.
The new study, published in the journal PLOS ONE, assessed the extent of household 'catastrophic dental health expenditure' (CDHE) in 41 low and middle income countries. Expenditure was defined as catastrophic if it was equal to or higher than 40% of the household's capacity to pay.
Up to 7% of the households surveyed in these countries had incurred catastrophic dental health expenditure in ...
New Haven, Conn.--Improving access to public toilets in South African urban settlements may reduce both the incidence of sexual assaults by nearly 30% and the overall cost to society, a study by researchers at the Yale School of Public Health and Yale School of Management found.
The research was published April 29 in PLOS ONE.
Development and human rights organizations have pointed to inadequate local sanitation facilities as a key factor in a woman's risk for physical or sexual assault. Many women in South Africa must travel out of their homes to public toilets, ...
The Public Health Agency of Sweden has developed a method of typing that can allow laboratories to faster establish the presence of hospital outbreaks of the intestinal bacterium Clostridium difficile. The findings are now published in PLOS ONE.
The Clostridium difficile bacteria exist in the intestines of 2-5 per cent of the healthy population, and is rather common among infants. In certain circumstances the bacteria can induce diarrhea in persons treated with antibiotics. The diarrhea is in some cases serious.
The majority of the cases occur at hospitals. This is ...
HOUSTON - (April 29, 2015) - Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and the Texas Children's Hospital have expanded the use of virus-specific cell therapy in cord blood transplant patients to successfully prevent three of the most problematic post-transplant viruses affecting this group of patients that have yet to be addressed clinically - cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus.
The team published their results of a clinical trial that evaluated the safety and efficacy of the therapy ...
Scientists have identified chemical markers in urine associated with body mass, providing insights into how obesity causes disease.
Being overweight or obese is associated with higher risk of heart disease, stroke, diabetes and cancer, but the mechanisms connecting body fat and disease are not well understood.
The new study, led by Imperial College London, shows that obesity has a 'metabolic signature' detectable in urine samples, pointing to processes that could be targeted to mitigate its effects on health. The findings are published in Science Translational Medicine.
Urine ...
Locally-sourced antibiotics can be as effective as 'internationally quality-assured' (IQA) antibiotics for treating multidrug-resistant tuberculosis (MDR-TB) in Pakistan, and may help avoid delays in starting treatment while programmes wait for drugs to arrive from overseas, according to new research published in PLOS ONE.
The study is the first to compare outcomes of MDR-TB patients treated using IQA drugs with those treated using locally procured drugs in the same hospitals over the same period. It was a collaboration between researchers from the London School of ...
